KeraVet Bio selected as an ‘Emerging Company’

By Michelle Barson, KeraVet Bio Staff

KeraVet Bio is excited to announce that we have been chosen as a KC Animal Health Corridor Emerging Company for their 17th Annual Animal Health Summit in Kansas City, Kansas. Presentations will be made on August 30th at the Midland Theatre in Kansas City’s Power & Light District throughout the morning and early afternoon for all attendees to observe. Each presenter will receive 10 minutes to present their company and product to a panel of elite judges made up of animal health industry leaders.

Emerging Companies are chosen from applicants who are early-stage animal health, nutrition, diagnostic and technology companies. These companies are all seeking investments or strategic partnerships.  Being chosen as an Emerging Company provides an opportunity to work side-by-side, and later present to, animal health industry leaders and investors.

Once selected by the Animal Health Summit Selection Committee, companies receive coaching from a panel of animal health industry experts that includes assistance with developing a pitch, mentoring, practice pitch sessions with feedback, promotion to qualified investors and media promotion.  There are three formal coaching sessions with the larger group and an opportunity to work one-on-one, as desired, with a dedicated individual coaching partner.

2022 Selection Committee

Samer Al-Murrani, PhD

Managing Director, Babylon BioConsulting LLC

Emily Aston, DVM, PhD

Senior Program Manager, TechAccel

Jim Kroman

Senior Consultant, Brakke Consulting

Crissa Cook, JD

Partner, Hovey Williams LLP

Kerryman Kocher

Chief Executive Officer at Vytelle

Brett Morris, CFA 

Managing Director at Cavallo Ventures

Chris Ragland

CEO, Animalytix, LLC

Edward Robb DVM, MS, DACVIM (Nutrition)

CEO, BioPharmaPotentials LLC (BPP)

Donald Schwartz

Principal, Elders Rede LLC | Animal Health Industry Advisors

Rich Shuler

President & CEO, Shuler Consulting Services

Tony Simpson

President, AgTech Advisors, LLC

Laura Treml, VMD. PhD

VP Commercial Development, Companion Animal Division, Phibro Animal Health Corporation

Craig Wallace

Owner, C.S. Wallace Investments + Strategy